177 related articles for article (PubMed ID: 9322621)
1. Angiogenesis in primary and metastatic epithelial ovarian carcinoma.
Abulafia O; Triest WE; Sherer DM
Am J Obstet Gynecol; 1997 Sep; 177(3):541-7. PubMed ID: 9322621
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in early-invasive and low-malignant-potential epithelial ovarian carcinoma.
Abulafia O; Ruiz JE; Holcomb K; Dimaio TM; Lee YC; Sherer DM
Obstet Gynecol; 2000 Apr; 95(4):548-52. PubMed ID: 10725487
[TBL] [Abstract][Full Text] [Related]
3. The influence of microvessel density on ovarian carcinogenesis.
Stone PJ; Goodheart MJ; Rose SL; Smith BJ; DeYoung BR; Buller RE
Gynecol Oncol; 2003 Sep; 90(3):566-71. PubMed ID: 13678725
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis in advanced stage ovarian carcinoma.
Hollingsworth HC; Kohn EC; Steinberg SM; Rothenberg ML; Merino MJ
Am J Pathol; 1995 Jul; 147(1):33-41. PubMed ID: 7541612
[TBL] [Abstract][Full Text] [Related]
5. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of angiogenesis in epithelial ovarian carcinoma.
Alvarez AA; Krigman HR; Whitaker RS; Dodge RK; Rodriguez GC
Clin Cancer Res; 1999 Mar; 5(3):587-91. PubMed ID: 10100710
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma.
Raspollini MR; Amunni G; Villanucci A; Baroni G; Boddi V; Taddei GL
Int J Gynecol Cancer; 2004; 14(5):815-23. PubMed ID: 15361189
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in endometrial carcinoma.
Kaku T; Kamura T; Kinukawa N; Kobayashi H; Sakai K; Tsuruchi N; Saito T; Kawauchi S; Tsuneyoshi M; Nakano H
Cancer; 1997 Aug; 80(4):741-7. PubMed ID: 9264358
[TBL] [Abstract][Full Text] [Related]
9. Expression of thymidine phosphorylase in malignant ovarian tumors: correlation with microvessel density and an ultrasound-derived index of angiogenesis.
Hata K; Nagami H; Iida K; Miyazaki K; Collins WP
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):201-6. PubMed ID: 9793193
[TBL] [Abstract][Full Text] [Related]
10. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
[TBL] [Abstract][Full Text] [Related]
11. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
[TBL] [Abstract][Full Text] [Related]
12. Tumor angiogenesis and thymidine phosphorylase expression in ovarian carcinomas including serous surface papillary adenocarcinoma of the peritoneum.
Terai Y; Ueda M; Kumagai K; Ueki K; Ueki M
Int J Gynecol Pathol; 2000 Oct; 19(4):354-60. PubMed ID: 11109165
[TBL] [Abstract][Full Text] [Related]
13. Preoperative omental metastasis-related maximum standardized fluorine-18-fluorodeoxyglucose uptake value can predict chemosensitivity and recurrence in advanced high-grade serous ovarian cancer patients.
Sun Y; Liu S; Feng Z; Cheng J; Lu L; Wang M; Yuan H; Xu J; Zhang Y
Nucl Med Commun; 2018 Aug; 39(8):761-767. PubMed ID: 30001265
[TBL] [Abstract][Full Text] [Related]
14. Intratumor heterogeneity of morphometric and stereologic variables in primary ovarian tumors and their omental metastatic deposits.
Brinkhuis M; Scheepstra C; Buist MR; van Diest PJ; Baak JP
Anal Quant Cytol Histol; 1997 Jun; 19(3):185-93. PubMed ID: 9196800
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis.
Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R
Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
Fontanini G; Lucchi M; Vignati S; Mussi A; Ciardiello F; De Laurentiis M; De Placido S; Basolo F; Angeletti CA; Bevilacqua G
J Natl Cancer Inst; 1997 Jun; 89(12):881-6. PubMed ID: 9196255
[TBL] [Abstract][Full Text] [Related]
17. Ovarian carcinoma apparently confined to the ovaries--the accuracy of surgical staging in Israel.
Menczer J; Chetrit A; Sadetzki S;
Eur J Gynaecol Oncol; 2009; 30(4):375-8. PubMed ID: 19761125
[TBL] [Abstract][Full Text] [Related]
18. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma.
Takebayashi Y; Aklyama S; Yamada K; Akiba S; Aikou T
Cancer; 1996 Jul; 78(2):226-31. PubMed ID: 8673996
[TBL] [Abstract][Full Text] [Related]
20. Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity.
Hata K; Fujiwaki R; Maede Y; Nakayama K; Fukumoto M; Miyazaki K
Gynecol Oncol; 2000 Apr; 77(1):26-34. PubMed ID: 10739687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
